Women's Health

Session # 317

Prospective evaluation of a facilitated referral pathway to improve uptake of genetic assessment for women with newly diagnosed ovarian cancer.

Approximately 30% of ovarian cancer is attributable to germline mutations and genetic assessment is recommended for all women with ovarian cancer. However, only 15-30% of women are currently being offered genetic evaluation. We sought to determine if a patient-centered, facilitated genetics referral pathway whereby all newly diagnosed ovarian cancer patients are immediately contacted by a genetics navigator to schedule genetic assessment as part of routine care could increase rates of genetic counseling and uptake of genetic testing.

  • Authors: Melissa Frey; Sarah Lee; Jessica Martineau; Jing-Yi Chern; Emily Dalton; Courtney Grosvenor; Leslie Boyd; Bhavana Pothuri; John Curtin; Stephanie Blank
  • Conference: Society of Gynecologic Oncology (SGO)
  • Date: Monday, Mar 13, 2017 3:30pm - 4:30pm

Search Results

Start your search...